Those receiving a combination of angiotensin-II stimulating and inhibiting antihypertensive drugs did not have significantly different risks of AD, vascular dementia, DLB, FTD, and MCI, but had a significantly higher risk of other dementia and total ADRD. The gene discussed is AGT; the disease is Alzheimer disease.